Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Short Bursts of Exercise Linked To Lower Risk of Major Diseases

TUESDAY, March 31, 2026 As it turns out, you don t need long workouts to improve your health. Just a few minutes of more intense activity each day may help lowe

Sex Enhancement Chocolates Recalled Over Hidden Drug Ingredients

TUESDAY, March 31, 2026 Two chocolate products marketed for sexual enhancement are being recalled because they were found to contain hidden prescription drug in

Over 10.2 Million Grill Brushes Recalled Over Metal Bristle Risk

TUESDAY, March 31, 2026 Millions of grill brushes are being recalled following reports that small metal bristles can break off and end up in food. The U.S. Cons

Global Maternal Mortality Ratio Reported at 190.5 Deaths/100,000 Livebirths in 2023

In 2023, the global maternal mortality ratio (MMR) was 190.5 maternal deaths per 100,000 livebirths, according to a study published online March 26 in The Lance

EBCC: Axillary Radiotherapy Without Lymphadenectomy Feasible for Breast Cancer

For patients with breast cancer with limited nodal disease after neoadjuvant therapy, axillary radiotherapy (ART) is as effective as axillary lymphadenectomy (A

Online Tool Enables Communication of Genetic Testing Results With Family Members

A new online tool may help cancer patients communicate genetic testing results with family, according to a study published online March 24 in the Journal of Cli

More Than 250,000 Global Deaths From Meningitis Reported in 2023

In 2023, there were 259,000 global deaths and 2.54 million incident cases of meningitis, according to a study published online March 27 in The Lancet Neurology.

Major Cardiovascular Event Risk Increased With Discontinuation of GLP-1 RAs in T2D

For adults with type 2 diabetes, discontinuation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for major adverse

Repatha Cuts Risk of First Major Cardiovascular Events By 31% In High-risk Patients Without Known Significant Atherosclerosis

Amgen (NASDAQ AMGN) announced today that Repatha (evolocumab), when added to statins or other low-density lipoprotein cholesterol (LDL-C)-lowering treatments, r

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

Priovant Therapeutics, a clinical-stage biotechnology company focused on developing targeted therapeutics in autoimmune disease, announced today the publication

Popular Keywords